Catalyst Wire Dossier Catalyst Wire Dossier

Zeushield Cytotoxic T Lymphocytes (Z-CTLs)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zeushield Cytotoxic T Lymphocytes (Z-CTLs), covering 2017-02-23 to 2017-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Zeushield Cytotoxic T Lymphocytes (Z-CTLs) for Relapsed or Refractory Non Small Cell Lung Cancer (NSCLC) [EARLY_Phase 1]

See pricing